Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 4 2Phase 1/2 2Phase 1 2Phase NA 1Phase 3 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Myeloid 2Lymphoid 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 60Lymphoma 35Lymphoma, Follicular 31Lymphoma, Non-Hodgkin 30Leukemia, Lymphocytic, Chronic, B-Cell 16Recurrence 11Lymphoma, Large B-Cell, Diffuse 11Leukemia 11Lymphoma, B-Cell 10Waldenstrom Macroglobulinemia 8Lymphoma, T-Cell, Cutaneous 8Hodgkin Disease 8Mycosis Fungoides 6Lymphoma, Mantle-Cell 6Neoplasm, Residual 5Lymphoma, T-Cell, Peripheral 5Lymphoma, T-Cell 5Lymphoma, Extranodal NK-T-Cell 5Febrile Neutropenia 5Burkitt Lymphoma 5Asthma 5Pain 4Neoplasms 4Multiple Myeloma 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Myeloid, Acute 4Hematologic Diseases 4Sezary Syndrome 3Neoplasms, Plasma Cell 3Myelodysplastic Syndromes 3

Interventions

zanubrutinib 1ruxolitinib 1pegaspargase 1Rituximab 1Gemcitabine 1Etoposide 1Dexamethasone 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Lymphohistiocytosis, Hemophagocytic × Lymphoid × Clear all
NCT07270835 2025-12-08

Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma

The First Affiliated Hospital of Soochow University

Phase 4 Recruiting
40 enrolled
LymphoidMyeloid

Lymphoma, B-Cell, Lymphohistiocytosis, Hemophagocytic

NCT04999878 2021-08-11

RUE-DDGP

Zhengzhou University

Phase 4 Unknown
30 enrolled
LymphoidMyeloid

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡